Skip to main content
SpringerLink
Log in

Solubility Improvement of Drugs using N-Methyl Pyrrolidone

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The solubilization efficiency of N-methyl pyrrolidone (NMP) has been determined and compared to that of ethanol and propylene glycol for 13 poorly soluble drugs. NMP is found to be a more efficient solubilizer for all the drugs studied. The solubility enhancement as high as about 800-fold is obtained in 20% v/v NMP solution as compared to water. The mechanism of drug solubilization by NMP has also been investigated. It is proposed that NMP enhances drug solubility by simultaneously acting as a cosolvent and a complexing agent. A mathematical model is used to estimate the drug solubility in NMP–water mixture, according to which the total solubility enhancement is a sum of the two effects. This model describes the experimental data well and is more accurate than other models. A large and uniform reduction in the surface tension of water as a function of NMP concentration demonstrates its cosolvent effect. The complexation is supported by the fact that it’s strength is affected by the temperature and the polarity of the medium. A strong correlation exists between log K ow of the drugs and the cosolvency coefficients. The correlation between log K ow and the complexation coefficients is weak suggesting that factors such as molecular shape and aromaticity of the drug molecule are significant in determining the complexation strength. This has been confirmed by the absence of a significant complexation between NMP and linear drug-like solutes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. R. Tarantino, E. Bishop, C. Fang-Chung, K. Iqbal, and W. A. Malick. N-methyl-2-pyrrolidone as a cosolvent: relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds. J. Pharm. Sci. 83:1213–1216 (1994).

    Article  PubMed  CAS  Google Scholar 

  2. P. L. Lee, R. Langer, and V. P. Shastri. Role of N-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J. Pharm. Sci. 94:912–917 (2005).

    Article  PubMed  CAS  Google Scholar 

  3. A. J. Aguiar, W. A. Armstrong, and S. J. Desai. Development of oxytetracyclin long-acting injectable. J Control Release. 6:375–385 (1987).

    Article  CAS  Google Scholar 

  4. A. S. Uch, U. Hesse, and J. B. Dressman. Use of 1-methyl pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs. Pharm. Res. 16:968–971 (1999).

    Article  PubMed  CAS  Google Scholar 

  5. W. Bartsch, G. Sponer, K. Dietmann, and G. Fuchs. Acute Toxicity of various Solvents in the Mouse and Rat. Drug Res. 26:1581–1583 (1976).

    CAS  Google Scholar 

  6. P. Jain, and S. H. Yalkowsky. Solubilization of poorly soluble compounds using 2-Pyrrolidone. Int. J. Pharm. 3421:1–5 (2007).

    Article  PubMed  CAS  Google Scholar 

  7. D. Khossravi, and K. A. Connors. Solvent effects on chemical processes, I: Solubility of aromatic and heterocyclic compounds in binary aqueous–organic solvents. J. Pharm. Sci. 814:371–379 (1992).

    Article  PubMed  CAS  Google Scholar 

  8. P. B. Myrdal, G. H. Ward, R. M. Dannenfelser, D. Mishra, and S. H. Yalkowsky. AQUAFAC 1: Aqueous functional group activity coefficients; application to hydrocarbons. Chemosphere 24:1047–1061 (1992).

    Article  CAS  Google Scholar 

  9. J. H. Hildebrand. Solubility XII—regular solutions. J. Am. Chem. Soc. 49:1–29 (1929).

    Google Scholar 

  10. A. N. Paruta, B. J. Sciarrone, and N. G. Lordi. Solubility of salicylic acid as a function of dielectric constants. J. Pharm. Sci. 53:1349–1353 (1964).

    Article  PubMed  CAS  Google Scholar 

  11. A. Martin, J. Newburger, and A. Adjei. Extended Hilderbrand solubility approach: solubility of theophyllin in polar binary solvents. J. Pharm. Sci. 69:487–490 (1980).

    Article  PubMed  CAS  Google Scholar 

  12. A. Martin, A. N. Paruta, and A. Adjei. Extended Hildebrand solubility approach: Methyl Xanthines in Mixed Solvents. J. Pharm. Sci. 70:1115–1119 (1981).

    Article  PubMed  CAS  Google Scholar 

  13. S. H. Yalkowsky, G. L. Amidon, G. Zografi, and G. L. Flynn. Solubilization of nonelectrolytes in polar solvents: III. Alkyl p-aminobenzoates in polar and mixed solvents. J. Pharm. Sci. 64:48–52 (1972).

    Article  Google Scholar 

  14. S. H. Yalkowsky, and T. J. Roseman. Techniques of Solubilization of Drugs, Chapter 3. Marcel Dekker, New York, 1981.

  15. A. Li, and S. H. Yalkowsky. Solubility of organic solutes in ethanol–water mixtures. J. Pharm. Sci. 83:1735–1740 (1994).

    Article  PubMed  CAS  Google Scholar 

  16. S. G. Machatha, and S. H. Yalkowsky. Bilinear model for the prediction of solubility in ethanol/water mixtures. J. Pharm. Sci. 94:2731–2734 (2005).

    Article  PubMed  CAS  Google Scholar 

  17. J. W. Millard, F. A. Alvarez-Nunez, and S. H. Yalkowsky. Solubilization by cosolvents establishing useful constants for the log-linear model. Int. J. Pharm. 245:153–166 (2002).

    Article  PubMed  CAS  Google Scholar 

  18. J. T. Rubino. Solubilization of some poorly soluble drugs by cosolvents. Ph.D. Thesis. The University of Arizona, 1984.

  19. E. I. Maloka, and S. Y. Ibrahim. Physical properties of aqueous N-methyl pyrrolidone at different temperatures. Pet. Sci. Tech. 22:1571–1579 (2004).

    Article  CAS  Google Scholar 

  20. H. Suzuki, and H. Sunada. Mechanistic studies of hydrotropic solubilization of Nifedipine in nicotinamide solution. Chem. Pharm. Bull. 46:125–130 (1998).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, The University of Arizona, 1703 E. Mabel Street, Tucson, Arizona, 85721-0207, USA

    Ritesh Sanghvi & Samuel H. Yalkowsky

  2. Formulation Research Laboratory, Eisai. Co. Ltd., Kakamigahara, Gifu, 501-6195, Japan

    Ryuichi Narazaki

  3. Cydex Inc., Lenexa, Kansas, 66214, USA

    Stephen G. Machatha

Authors
  1. Ritesh Sanghvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryuichi Narazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen G. Machatha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samuel H. Yalkowsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ritesh Sanghvi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanghvi, R., Narazaki, R., Machatha, S.G. et al. Solubility Improvement of Drugs using N-Methyl Pyrrolidone. AAPS PharmSciTech 9, 366–376 (2008). https://doi.org/10.1208/s12249-008-9050-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9050-z

Key words

Search

Navigation